These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 1496694)
1. Immunophilin structure: a template for immunosuppressive drug design? Walkinshaw MD; Kallen J; Weber HP; Widmer A; Widmer H; Zurini M Transplant Proc; 1992 Aug; 24(4 Suppl 2):8-13. PubMed ID: 1496694 [No Abstract] [Full Text] [Related]
2. Structure-function relationships in the FK506-binding protein (FKBP) family of peptidylprolyl cis-trans isomerases. Kay JE Biochem J; 1996 Mar; 314 ( Pt 2)(Pt 2):361-85. PubMed ID: 8670043 [No Abstract] [Full Text] [Related]
3. Cyclosporin A, FK506, and rapamycin: binding to immunophilins and biological action. Bierer BE Chem Immunol; 1994; 59():128-55. PubMed ID: 7524531 [No Abstract] [Full Text] [Related]
4. Immunosuppression. Binding by design. Ringe D Nature; 1991 May; 351(6323):185-6. PubMed ID: 1710317 [No Abstract] [Full Text] [Related]
5. Cyclosporin binding proteins. Identification, distribution, function and relation to FK binding proteins. Ryffel B Biochem Pharmacol; 1993 Jul; 46(1):1-12. PubMed ID: 8394072 [No Abstract] [Full Text] [Related]
6. Molecular mechanisms of immunosuppressive agents. Borel JF; Baumann G Bull Mem Acad R Med Belg; 1994; 149(1-2):97-101; discussion 101-3. PubMed ID: 7531051 [TBL] [Abstract][Full Text] [Related]
8. Structure of human cyclophilin and its binding site for cyclosporin A determined by X-ray crystallography and NMR spectroscopy. Kallen J; Spitzfaden C; Zurini MG; Wider G; Widmer H; Wüthrich K; Walkinshaw MD Nature; 1991 Sep; 353(6341):276-9. PubMed ID: 1896075 [TBL] [Abstract][Full Text] [Related]
9. Prolyl isomerase: enzymatic catalysis of slow protein-folding reactions. Schmid FX Annu Rev Biophys Biomol Struct; 1993; 22():123-42. PubMed ID: 7688608 [No Abstract] [Full Text] [Related]
10. Yeast cyclophilin-related gene encodes a nonessential second peptidyl-prolyl cis-trans isomerase associated with the secretory pathway. Tanida I; Yanagida M; Maki N; Yagi S; Namiyama F; Kobayashi T; Hayano T; Takahashi N; Suzuki M Transplant Proc; 1991 Dec; 23(6):2856-61. PubMed ID: 1721297 [No Abstract] [Full Text] [Related]
11. Inhibition of T-cell signaling pathways by immunophilin drug complexes: are side effects inherent to immunosuppressive properties? Schreier MH; Baumann G; Zenke G Transplant Proc; 1993 Feb; 25(1 Pt 1):502-7. PubMed ID: 7679818 [No Abstract] [Full Text] [Related]
12. [Cyclophilin and FK506-binding protein]. Takahashi N Seikagaku; 1992 May; 64(5):325-31. PubMed ID: 1381737 [No Abstract] [Full Text] [Related]
14. Potential roles of other FK 506-binding proteins in mediating the effects of FK 506. Siekierka JJ; Wiederrecht G; Cryan J; Hung SH; Comisky M; Sigal NH Transplant Proc; 1991 Dec; 23(6):2720-1. PubMed ID: 1721256 [No Abstract] [Full Text] [Related]
16. Immunophilins, ligands, and the control of signal transduction. Schreiber SL; Crabtree GR Harvey Lect; 1995-1996; 91():99-114. PubMed ID: 9127988 [No Abstract] [Full Text] [Related]
17. Peptidyl-prolyl cis-trans isomerase of Bacillus subtilis: identification of residues involved in cyclosporin A affinity and catalytic efficiency. Göthel SF; Herrler M; Marahiel MA Biochemistry; 1996 Mar; 35(11):3636-40. PubMed ID: 8639516 [TBL] [Abstract][Full Text] [Related]
18. Modeling conformational changes in cyclosporin A. O'Donohue MF; Burgess AW; Walkinshaw MD; Treutlein HR Protein Sci; 1995 Oct; 4(10):2191-202. PubMed ID: 8535256 [TBL] [Abstract][Full Text] [Related]
19. The human erythrocyte membrane contains a novel 12-kDa inositolphosphate-binding protein that is an immunophilin. Cunningham EB Biochem Biophys Res Commun; 1995 Oct; 215(1):212-8. PubMed ID: 7575593 [TBL] [Abstract][Full Text] [Related]